FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alfred Witjes

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Johannes Falke; Rianne J M Lammers; Raffaella Pozzi; Miroslav Ravic; Henk Vergunst; Harm C Arentsen; Erik B Cornel; Theo M de Reijke; J Alfred Witjes
Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer.
Rianne J M Lammers; Cheryl T Lee; Richard J Sylvester; J Alfred Witjes
NMIBC risk calculators: how useful are they for the practicing urologist and how can their clinical utility be improved?
Cornelis G van Niekerk; J Alfred Witjes; Jelle O Barentsz; Jeroen A W M van der Laak; Christina A Hulsbergen-van de Kaa
Microvascularity in transition zone prostate tumors resembles normal prostatic tissue.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alfred Witjes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Johannes Falke; Rianne J M Lammers; Raffaella Pozzi; Miroslav Ravic; Henk Vergunst; Harm C Arentsen; Erik B Cornel; Theo M de Reijke; J Alfred Witjes
Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer.
The Journal of urology 2013;189(6):2077-82.
2013: Rianne J M Lammers; Cheryl T Lee; Richard J Sylvester; J Alfred Witjes
NMIBC risk calculators: how useful are they for the practicing urologist and how can their clinical utility be improved?
The Urologic clinics of North America 2013;40(2):155-64.
2013: Cornelis G van Niekerk; J Alfred Witjes; Jelle O Barentsz; Jeroen A W M van der Laak; Christina A Hulsbergen-van de Kaa
Microvascularity in transition zone prostate tumors resembles normal prostatic tissue.
The Prostate 2013;73(5):467-75.
2013: Julia J van Tol-Geerdink; Henk Vergunst; P C Weijerman; J Alfred Witjes; J W H Leer; E J N T van Lin; Inge van Oort; Peep F M Stalmeier
Quality of life after prostate cancer treatments in patients comparable at baseline.
British journal of cancer 2013;108(9):1784-9.
2013: Diederik M Somford; Inge van Oort; Henk Vergunst; J Alfred Witjes; Chris H Bangma; Jelle O Barentsz; Jurgen J Fütterer; Thomas Hambrock; Caroline M Hoeks; Christina A Hulsbergen-van de Kaa; Jorg R Oddens; Geert A Smits
Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer.
Investigative radiology 2013;48(3):152-7.
2013: Willem M Brinkman; Bas Kengen; Jan-Maarten Luursema; Barbara M A Schout; J Alfred Witjes; Ruud L Bekkers
da Vinci skills simulator for assessing learning curve and criterion-based training of robotic basic skills.
Urology 2013;81(3):562-6.
2013: J Alfred Witjes
Maintenance bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: do we finally know the best schedule?
European urology 2013;63(3):473-4.
2013: Irene M Tjiam; J Alfred Witjes; Ad J M Hendrikx; Arno M M Muijtjens; Albert J J A Scherpbier; Barbara M A Schout; Cees P M van der Vleuten
Program for laparoscopic urological skills assessment: setting certification standards for residents.
Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy 2013;22(1):26-32.
2013: Caroline M A Hoeks; Christina A Hulsbergen-van de Kaa; J Alfred Witjes; Derya Yakar; Ton Feuth; Jurgen J Fütterer; Thomas Hambrock; Jelle O Barentsz
Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
Radiology 2013;266(1):207-17.
2013: J Alfred Witjes
The impact of recurrent non-muscle-invasive bladder cancer on progression.
European urology 2013;63(1):155-7.
2013: Maximilian Burger; Sam Chang; Christopher Cheng; Eva Comperat; Colin Dinney; Sigurdur Gudjonsson; Badrinath Konety; Willem Oosterlinck; Wolfgang Otto; Raj Pruthi; Jay Shah; Mark Soloway; Eduardo Solsona; Paul Sved; Joachim Thürof; Marko Babjuk; Maurizio A Brausi; J Alfred Witjes
ICUD-EAU International Consultation on Bladder Cancer 2012: non-muscle-invasive urothelial carcinoma of the bladder.
European urology 2013;63(1):36-44.
2012: David R Yates; Alexandre R Zlotta; Maurizio Brausi; James W F Catto; Guido Dalbagni; Morgan Rouprêt; Shahrokh F Shariat; Richard J Sylvester; J Alfred Witjes; Juan Palou Redorta
Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.
European urology 2012;62(6):1088-96.
2012: Hanneke J M Meijer; Mack Roach; Paul N Span; Emile N J Th van Lin; J Alfred Witjes; Oscar A Debats; Johannes H A M Kaanders; Jelle O Barentsz
Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogram.
International journal of radiation oncology, biology, physics 2012;84(5):1186-91.
2012: H Max Bruins; Christina A Hulsbergen-van de Kaa; Lambertus A L M Kiemeney; Martine Ploeg; Otto Visser; J Alfred Witjes
The clinical epidemiology of urachal carcinoma: results of a large, population based study.
The Journal of urology 2012;188(4):1102-7.
2012: Arnulf Stenzl; J Alfred Witjes; Axel S Merseburger; Maria José Ribal; Amir Sherif; Nigel C Cowan; Maria De Santis; Markus A Kuczyk; Thierry Lebret
Reply to Santhanam Sundar's letter to the editor Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011;59:1009-18.
European urology 2012;62(2):e45-6.
2012: H Barton Grossman; Alexander Karl; Martin Kriegmair; Lance A Mynderse; Mark S Soloway; Arnulf Stenzl; J Alfred Witjes; Yves Fradet; Maximilian Burger
Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy.
The Journal of urology 2012;188(1):58-62.
2012: J Alfred Witjes
Prognosis of T1G3 bladder cancer: how well can we predict progression?
European urology 2012;62(1):126-7; discussion 128-9.
2012: Rianne J M Lammers; Christien T M Caris; Maria H D Janzing-Pastors; Wim P J Witjes; J Alfred Witjes
Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(18):2273-9.
2012: Seth P Lerner; Hao Liu; Yngvil K Thomas; Meng-Fen Wu; J Alfred Witjes
Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder.
Urologic oncology 2012;30(3):285-9.
2012: Martine Ploeg; Geert A Smits; Hans van Berkel; Erika van Boven; Henk Vergunst; Andre C Viddeleer; Katja K H Aben; Arno D H Geboers; Lambertus A L M Kiemeney; J Alfred Witjes
Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy.
Urologic oncology 2012;30(3):247-51.
2012: Irene M Tjiam; J Alfred Witjes; Ad J M Hendrikx; Arno M M Muijtjens; Marjolein C Persoon; Albert J J A Scherpbier
Program for laparoscopic urologic skills: a newly developed and validated educational program.
Urology 2012;79(4):815-20.
2012: Harm C Arentsen; Christina A Hulsbergen-van de Kaa; Cornelius F J Jansen; Jarmo Laihia; Lasse Leino; Egbert Oosterwijk; Liisa Pylkkänen; J Alfred Witjes
Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladder.
The Journal of urology 2012;187(4):1445-9.
2012: Kees Hendricksen; H C Arentsen; S Chawla; Erik B Cornel; Theo M de Reijke; J Alfred Witjes
Phase 2 study of adjuvant intravesical instillations of apaziquone for high risk nonmuscle invasive bladder cancer.
The Journal of urology 2012;187(4):1195-9.
2012: Hanneke J M Meijer; Paul N Span; Emile N J Th van Lin; J Alfred Witjes; Oscar A Debats; Johannes H A M Kaanders; Jelle O Barentsz
High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy.
International journal of radiation oncology, biology, physics 2012;82(4):1405-10.
2012: Diederik M Somford; Jean-Paul van Basten; Inge van Oort; J Alfred Witjes; Jurgen J Fütterer; Thomas Hambrock; Christina A Hulsbergen-van de Kaa; Herbert F M Karthaus; Jelle O Barentsz
Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
Investigative radiology 2012;47(3):153-8.
2012: Diederik M Somford; Jean-Pierre Cosyns; Lambertus A L M Kiemeney; Inge van Oort; J Alfred Witjes; Bertrand Tombal
Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy.
World journal of urology 2012;30(1):105-10.
2012: Irene M Tjiam; Ad J M Hendrikx; Albert J J M Scherpbier; Barbara M A Schout; J Alfred Witjes; Jeroen J G Van Merriënboer
Designing simulator-based training: an approach integrating cognitive task analysis and four-component instructional design.
Medical teacher 2012;34(10):e698-707.
2011: Maurizio Brausi; Roger Buckley; Marc Colombel; Donald Lamm; Joan Palou; Raj Persad; Mark S Soloway; J Alfred Witjes; Hideyuki Akaza; Andreas Böhle
A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group.
The Journal of urology 2011;186(6):2158-67.
2011: Johan F Langenhuijsen; Robert J W Louwe; Robert Jan Smeenk; Peter van Kollenburg; Johannes H A M Kaanders; J Alfred Witjes; Emile N J Th van Lin
Reduction of treatment volume and radiation doses to surrounding tissues with intraprostatic gold markers in prostate cancer radiotherapy.
Clinical genitourinary cancer 2011;9(2):109-14.
2011: Bianca A M H van Veggel; J Alfred Witjes; Lambertus A L M Kiemeney; Inge van Oort; Christina A Hulsbergen-van de Kaa
Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy.
Histopathology 2011;59(4):692-702.
2011: Caroline M A Hoeks; Henkjan J Huisman; Tom W J Scheenen; Diederik M Somford; Inge van Oort; Pieter C Vos; J Alfred Witjes; Derya Yakar; Jelle O Barentsz; Thomas Hambrock; Arend Heerschap; Stijn W T P J Heijmink; Jurgen J Fütterer
Prostate cancer: multiparametric MR imaging for detection, localization, and staging.
Radiology 2011;261(1):46-66.
2011: Rianne J M Lammers; Christien T M Caris; Kees Hendricksen; Maria H C Janzing-Pastors; Wim P J Witjes; J Alfred Witjes
Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer.
European urology 2011;60(4):713-20.
2011: Harm C Arentsen; Christina A Hulsbergen-van de Kaa; Cornelius F J Jansen; Lorenzo M Leoni; Roberto Maj; Egbert Oosterwijk; J Alfred Witjes
Pharmacokinetics and toxicity of intravesical TMX-101: a preclinical study in pigs.
BJU international 2011;108(7):1210-4.
2011: Johannes Falke; J Alfred Witjes
Perioperative management of nonmuscle-invasive bladder cancer.
Current opinion in urology 2011;21(5):403-8.
2011: Rianne J M Lammers; J Alfred Witjes; Brant A Inman; Ilan Leibovitch; Menachem Laufer; Ofer Nativ; Renzo Colombo
The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.
European urology 2011;60(1):81-93.
2011: Rianne J M Lammers; J Alfred Witjes
Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continues.
Expert review of anticancer therapy 2011;11(6):853-8.
2011: Stijn W T P J Heijmink; Jurgen J Fütterer; Stephen Strum; Wim J G Oyen; Ferdinand Frauscher; J Alfred Witjes; Jelle O Barentsz
State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer.
Acta oncologica (Stockholm, Sweden) 2011;50 Suppl 1():25-38.
2011: Arnulf Stenzl; Nigel C Cowan; Maria De Santis; Markus A Kuczyk; Axel S Merseburger; Maria José Ribal; Amir Sherif; J Alfred Witjes
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.
European urology 2011;59(6):1009-18.
2011: Alessandro Sciarra; Jelle Barentsz; Anders Bjartell; James Eastham; Hedvig Hricak; Valeria Panebianco; J Alfred Witjes
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.
European urology 2011;59(6):962-77.
2011: Joep G H van Roermund; Karel A Hinnen; Christine J Tolman; Gijsbert H Bol; J Alfred Witjes; J L H Ruud Bosch; Lambertus A Kiemeney; Marco van Vulpen
Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients.
BJU international 2011;107(11):1775-9.
2011: Thomas Hambrock; Diederik M Somford; Henkjan J Huisman; Inge van Oort; J Alfred Witjes; Christina A Hulsbergen-van de Kaa; Tom W J Scheenen; Jelle O Barentsz
Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
Radiology 2011;259(2):453-61.
2011: Marjolein C Persoon; Kim van Putten; Arno M M Muijtjens; J Alfred Witjes; A J M Hendrikx; Albert J J M Scherpbier
Effect of distraction on the performance of endourological tasks: a randomized controlled trial.
BJU international 2011;107(10):1653-7.
2011: Marjolein C Persoon; Hans J H P Broos; J Alfred Witjes; A J M Hendrikx; Albert J J M Scherpbier
The effect of distractions in the operating room during endourological procedures.
Surgical endoscopy 2011;25(2):437-43.
2011: Johannes Falke; J Alfred Witjes
Contemporary management of low-risk bladder cancer.
Nature reviews. Urology 2011;8(1):42-9.
2011: Cornelis G van Niekerk; Christina A Hulsbergen-van de Kaa; Jelle O Barentsz; J Alfred Witjes; Jeroen A W M van der Laak
Quantitative analysis of lymph vessel characteristics in organ confined prostate cancer.
The Prostate 2011;71(1):91-7.
2010: Rianne J M Lammers; J Alfred Witjes
Developments in intravesical therapy for non-muscle-invasive bladder cancer.
Expert review of anticancer therapy 2010;10(12):1903-16.
2010: Arnulf Stenzl; Maximilian Burger; Yves Fradet; Lance A Mynderse; Mark S Soloway; J Alfred Witjes; Martin Kriegmair; Alexander Karl; Yu Shen; H Barton Grossman
Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.
The Journal of urology 2010;184(5):1907-13.
2010: Marjolein C Persoon; Barbara Schout; Elisabeth J Martens; Irene M Tjiam; Alexander V Tielbeek; Albert J J A Scherpbier; J Alfred Witjes; Ad J M Hendrikx
A simulator for teaching transrectal ultrasound procedures: how useful and realistic is it?
Simulation in healthcare : journal of the Society for Simulation in Healthcare 2010;5(5):311-4.
2010: Olaf P J Vrooman; J Alfred Witjes
Follow-up of patients after curative bladder cancer treatment: guidelines vs. practice.
Current opinion in urology 2010;20(5):437-42.
2010: Marjolein C Persoon; Barbara M A Schout; Arno M M Muijtjens; Ad J M Hendrikx; J Alfred Witjes; Albert J J M Scherpbier
The effect of a low-fidelity model on cystoscopic skill training: a single-blinded randomized controlled trial.
Simulation in healthcare : journal of the Society for Simulation in Healthcare 2010;5(4):213-8.
2010: R S van der Post; Lambertus A L M Kiemeney; M J L Ligtenberg; J Alfred Witjes; Christina A Hulsbergen-van de Kaa; Daniëlle Bodmer; L Schaap; Carolien M Kets; J H J M van Krieken; Nicoline Hoogerbrugge
Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.
Journal of medical genetics 2010;47(7):464-70.
2010: J Alfred Witjes; Juan Palou Redorta; Didier Jacqmin; Frank Sofras; Per-Uno Malmstrom; Claus Riedl; Dieter Jocham; Giario Conti; Francesco Montorsi; Harm C Arentsen; Dirk Zaak; A Hugh Mostafid; Marko Babjuk
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations.
European urology 2010;57(4):607-14.
2010: Inge van Oort; H Maxim Bruins; Lambertus A L M Kiemeney; Ben C Knipscheer; J Alfred Witjes; Christina A Hulsbergen-van de Kaa
The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy.
Histopathology 2010;56(4):464-71.
2010: Derya Yakar; Thomas Hambrock; Henkjan Huisman; Christina A Hulsbergen-van de Kaa; Emile van Lin; Henk Vergunst; Caroline M A Hoeks; Inge M van Oort; J Alfred Witjes; Jelle O Barentsz; Jurgen J Fütterer
Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.
Investigative radiology 2010;45(3):121-5.
2010: Thomas Hambrock; Diederik M Somford; Caroline Hoeks; Stefan A W Bouwense; Henkjan J Huisman; Derya Yakar; Inge van Oort; J Alfred Witjes; Jurgen J Fütterer; Jelle O Barentsz
Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
The Journal of urology 2010;183(2):520-7.
2010: Martine M Goedendorp; Marlies E W J Peters; M F M Gielissen; J Alfred Witjes; Jan Willem Leer; C A H H V M Verhagen; Gijs Bleijenberg
Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trial.
The oncologist 2010;15(10):1122-32.
2010: Daphne Hessels; Martijn P M Q van Gils; Onno van Hooij; Sander A Jannink; J Alfred Witjes; Gerald W Verhaegh; Jack A Schalken
Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer.
The Prostate 2010;70(1):10-6.
2010: Joep G H van Roermund; Karel Hinnen; Jan J Battermann; J Alfred Witjes; J L H Ruud Bosch; Lambertus A Kiemeney; Marco van Vulpen
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy.
BJU international 2010;105(1):42-8.
2009: J Alfred Witjes
Editorial comment.
Urology 2009;74(6):1281.
2009: J Alfred Witjes; Giulio Del popolo; M Marberger; O Jonsson; H P Kaps; Christopher Chapple
A multicenter, double-blind, randomized, parallel group study comparing polyvinyl chloride and polyvinyl chloride-free catheter materials.
The Journal of urology 2009;182(6):2794-8.
2009: J Alfred Witjes
Editorial comment on: Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer.
European urology 2009;56(6):910.
2009: Cora N Sternberg; Daniel P Petrylak; Oliver Sartor; J Alfred Witjes; Tomasz Demkow; Jean-Marc Ferrero; Jean-Christophe Eymard; Silvia Falcon; Fabio Calabrò; Nicholas James; Istvan Bodrogi; Peter Harper; Manfred Wirth; William Berry; Michael E Petrone; Thomas J McKearn; Mojtaba Noursalehi; Martine George; Marcel Rozencweig
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5431-8.
2009: Justine Varinot; Philippe Camparo; Morgan Roupret; Marc-Olivier Bitker; Fréderique Capron; Olivier Cussenot; J Alfred Witjes; Eva Compérat
Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage.
Virchows Archiv : an international journal of pathology 2009;455(5):449-53.
2009: Ofer Nativ; J Alfred Witjes; Kees Hendricksen; Michael Cohen; Daniel Kedar; Ami Sidi; Renzo Colombo; Ilan Leibovitch
Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin.
The Journal of urology 2009;182(4):1313-7.
2009: Bas W G van Rhijn; Maximilian Burger; Yair Lotan; Eduardo Solsona; Christian G Stief; Richard J Sylvester; J Alfred Witjes; Alexandre R Zlotta
Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.
European urology 2009;56(3):430-42.
2009: Roel Peter Engel; J Alfred Witjes
Perioperative instillation therapy in superficial bladder cancer: is it effective regarding outcome and costs?
Current opinion in urology 2009;19(5):511-5.
2009: Inge van Oort; Dieuwertje E G Kok; Lambertus A Kiemeney; Christina A Hulsbergen-van de Kaa; J Alfred Witjes
A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or "insignificant".
Urologic oncology 2009;27(5):509-13.
2009: Per-Uno Malmstrom; Richard J Sylvester; David E Crawford; Martin Friedrich; Susanne Krege; Erkki Rintala; Eduardo Solsona; Savino M Di Stasi; J Alfred Witjes
An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.
European urology 2009;56(2):247-56.
2009: Joep G H van Roermund; Dieuwertje E G Kok; Mark F Wildhagen; Lambertus A L M Kiemeney; Femke Struik; Sarah Sloot; Inge van Oort; Christina A Hulsbergen-van de Kaa; Geert J L H van Leenders; Chris H Bangma; J Alfred Witjes
Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.
BJU international 2009;104(3):321-5.
2009: J Alfred Witjes
Topic issue on new treatments in bladder cancer.
World journal of urology 2009;27(3):285-7.
2009: Harm C Arentsen; Kees Hendricksen; Egbert Oosterwijk; J Alfred Witjes
Experimental rat bladder urothelial cell carcinoma models.
World journal of urology 2009;27(3):313-7.
2009: Kees Hendricksen; Antoine G van der Heijden; Erik B Cornel; Henk Vergunst; Theo M de Reijke; Erika van Boven; Geert A H J Smits; Rajiv Puri; Sigrid Gruijs; J Alfred Witjes
Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer.
World journal of urology 2009;27(3):337-42.
2009: J Alfred Witjes
Management of the first recurrence of T1G3 bladder cancer: does intravesical chemotherapy deserve a chance?
Urologic oncology 2009;27(3):322-4.
2009: Roel A M Heesakkers; Gerrit J Jager; Anke M Hövels; Bartjan de Hoop; Harrie C M van den Bosch; Frank Raat; J Alfred Witjes; Peter F A Mulders; Christina Hulsbergen van der Kaa; Jelle O Barentsz
Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
Radiology 2009;251(2):408-14.
2009: Arnulf Stenzl; Nigel C Cowan; Maria De Santis; Gerhard Jakse; Markus A Kuczyk; Axel S Merseburger; Maria José Ribal; Amir Sherif; J Alfred Witjes
The updated EAU guidelines on muscle-invasive and metastatic bladder cancer.
European urology 2009;55(4):815-25.
2009: Stijn W T P J Heijmink; Tom W J Scheenen; Emile N J Th van Lin; Andries Visser; Lambertus A L M Kiemeney; J Alfred Witjes; Jelle O Barentsz
Changes in prostate shape and volume and their implications for radiotherapy after introduction of endorectal balloon as determined by MRI at 3T.
International journal of radiation oncology, biology, physics 2009;73(5):1446-53.
2009: J Alfred Witjes
Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
European urology 2009;55(4):919.
2009: Olaf P J Vrooman; J Alfred Witjes
Molecular markers for detection, surveillance and prognostication of bladder cancer.
International journal of urology : official journal of the Japanese Urological Association 2009;16(3):234-43.
2009: Joep G H van Roermund; Jean-Paul A van Basten; Lambertus A Kiemeney; Herbert F M Karthaus; J Alfred Witjes
Impact of obesity on surgical outcomes following open radical prostatectomy.
Urologia internationalis 2009;82(3):256-61.
2009: Cornelis G van Niekerk; Jeroen A W M van der Laak; M Elisa Börger; Henkjan J Huisman; J Alfred Witjes; Jelle O Barentsz; Christina A Hulsbergen-van de Kaa
Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue.
The Prostate 2009;69(1):62-9.
2008: Christopher S D Lee; Cheol Yong Yoon; J Alfred Witjes
The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology.
BJU international 2008;102(9 Pt B):1228-33.
2008: Jack J A van Asten; Vincent Cuijpers; Christina A Hulsbergen-van de Kaa; Claudia Soede-Huijbregts; J Alfred Witjes; Albert A J Verhofstad; Arend Heerschap
High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies.
Magma (New York, N.Y.) 2008;21(6):435-42.
2008: Gerald W Verhaegh; Linda Verkleij; Sita H H M Vermeulen; Martin den Heijer; J Alfred Witjes; Lambertus A L M Kiemeney
Polymorphisms in the H19 gene and the risk of bladder cancer.
European urology 2008;54(5):1118-26.
2008: Thomas Hambrock; Jurgen J Fütterer; Henkjan J Huisman; Christina Hulsbergen-vandeKaa; Jean-Paul van Basten; Inge van Oort; J Alfred Witjes; Jelle O Barentsz
Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
Investigative radiology 2008;43(10):686-94.
2008: Roel A M Heesakkers; Anke M Hövels; Gerrit J Jager; Harrie C M van den Bosch; J Alfred Witjes; Hein P J Raat; Johan L Severens; Eddy M M Adang; Christina Hulsbergen van der Kaa; Jurgen J Fütterer; Jelle Barentsz
MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.
The lancet oncology 2008;9(9):850-6.
2008: Kirsten Pondman; Jurgen J Fütterer; Bennie ten Haken; Leo J Schultze Kool; J Alfred Witjes; Thomas Hambrock; Katarzyna J Macura; Jelle O Barentsz
MR-guided biopsy of the prostate: an overview of techniques and a systematic review.
European urology 2008;54(3):517-27.
2008: Martijn P M Q van Gils; Daphne Hessels; Christina A Hulsbergen-van de Kaa; J Alfred Witjes; Cornelius F J Jansen; Peter F A Mulders; Harry G Rittenhouse; Jack A Schalken
Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results.
The Prostate 2008;68(11):1215-22.
2008: Inge van Oort; J Alfred Witjes; Dieuwertje E G Kok; Lambertus A L M Kiemeney; Christina A Hulsbergen-van de Kaa
The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.
BJU international 2008;102(4):438-41.
2008: J Alfred Witjes; Prasad S Kolli
Apaziquone for non-muscle invasive bladder cancer: a critical review.
Expert opinion on investigational drugs 2008;17(7):1085-96.
2008: Kees Hendricksen; D Gleason; J M Young; D Saltzstein; A Gershman; S Lerner; J Alfred Witjes
Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
The Journal of urology 2008;180(1):116-20.
2008: Paul Span; J Alfred Witjes; Nicolai Grebenchtchikov; Anneke Geurts-Moespot; Paula M J Moonen; Tilly W Aalders; Jessica L J Vriesema; Lambertus A L M Kiemeney; Jack A Schalken; Fred C G J Sweep
Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues.
BJU international 2008;102(2):177-82.
2008: Inge van Oort; J Alfred Witjes; D E G Kok; Lambertus A L M Kiemeney; C A Hulsbergen-vandeKaa
Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer.
World journal of urology 2008;26(3):237-41.
2008: J Roan Spermon; J Alfred Witjes
Case report: the danger of postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma.
Journal of endourology / Endourological Society 2008;22(5):1013-6.
2008: Kees Hendricksen; Wim P J Witjes; Jan G Idema; Jan J M Kums; Oncko B van Vierssen Trip; Marcel J F M de Bruin; Henk Vergunst; Christien T M Caris; Maria H D Janzing-Pastors; J Alfred Witjes
Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer.
European urology 2008;53(5):984-91.
2008: Olaf P J Vrooman; J Alfred Witjes
Urinary markers in bladder cancer.
European urology 2008;53(5):909-16.
2008: Richard J Sylvester; Willem Oosterlinck; J Alfred Witjes
The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials.
European urology 2008;53(4):709-19.
2008: Kees Hendricksen; Janneke Molkenboer-Kuenen; Egbert Oosterwijk; Christina A Hulsbergen-van de Kaa; J Alfred Witjes
Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy.
BJU international 2008;101(7):889-93.
2008: Lambertus A L M Kiemeney; M J M Broeders; Marjon Pelger; Paul J Kil; Fritz H Schröder; J Alfred Witjes; H F A Vasen
Screening for prostate cancer in Dutch hereditary prostate cancer families.
International journal of cancer. Journal international du cancer 2008;122(4):871-6.
2008: J Alfred Witjes; Kees Hendricksen
Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results.
European urology 2008;53(1):45-52.
2007: Tom W J Scheenen; Stijn W T P J Heijmink; Stefan A Roell; Christina A Hulsbergen-van de Kaa; Ben C Knipscheer; J Alfred Witjes; Jelle O Barentsz; Arend Heerschap
Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility.
Radiology 2007;245(2):507-16.
2007: J Alfred Witjes
What is the optimal BCG dose in non-muscle-invasive bladder cancer?
European urology 2007;52(5):1300-2.
2007: Johan F Langenhuijsen; Emile N J Th van Lin; Lambertus A L M Kiemeney; Lisette P van der Vight; Gill M McColl; Andries Visser; J Alfred Witjes
Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors.
International journal of radiation oncology, biology, physics 2007;69(3):671-6.
2007: J Alfred Witjes; Jude Douglass
The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.
Nature clinical practice. Urology 2007;4(10):542-9.
2007: Joep G H van Roermund; J Alfred Witjes
The impact of obesity on prostate cancer.
World journal of urology 2007;25(5):491-7.
2007: Inge van Oort; K Tomita; A van Bokhoven; M J G Bussemakers; Lambertus A L M Kiemeney; Herbert F M Karthaus; J Alfred Witjes; Jack A Schalken
The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.
The Prostate 2007;67(13):1432-8.
2007: Daphne Hessels; Frank P Smit; Gerald W Verhaegh; J Alfred Witjes; Erik B Cornel; Jack A Schalken
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(17):5103-8.
2007: Kees Hendricksen; J Alfred Witjes
Current strategies for first and second line intravesical therapy for nonmuscle invasive bladder cancer.
Current opinion in urology 2007;17(5):352-7.
2007: Geert J L H van Leenders; Danny F Dukers; Daphne Hessels; Susan W M van den Kieboom; Christina A Hulsbergen; J Alfred Witjes; Arie P Otte; Chris J Meijer; Frank M Raaphorst
Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
European urology 2007;52(2):455-63.
2007: Paula M J Moonen; Judith M J E Bakkers; Lambertus A L M Kiemeney; Jack A Schalken; Willem J G Melchers; J Alfred Witjes
Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer.
European urology 2007;52(2):464-8.
2007: Stijn W T P J Heijmink; Jurgen J Fütterer; Thomas Hambrock; satoru takahashi; Tom W J Scheenen; Henkjan J Huisman; Christina A Hulsbergen-van de Kaa; Ben C Knipscheer; Lambertus A L M Kiemeney; J Alfred Witjes; Jelle O Barentsz
Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.
Radiology 2007;244(1):184-95.
2007: Antoine G van der Heijden; Christina A Hulsbergen-van de Kaa; J Alfred Witjes
The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis.
World journal of urology 2007;25(3):303-8.
2007: Martijn P M Q van Gils; Erik B Cornel; Daphne Hessels; W Pim Peelen; J Alfred Witjes; Peter F A Mulders; Harry G Rittenhouse; Jack A Schalken
Molecular PCA3 diagnostics on prostatic fluid.
The Prostate 2007;67(8):881-7.
2007: Paula M J Moonen; Gerard F M Merkx; Pim Peelen; Herbert F M Karthaus; Dominique Smeets; J Alfred Witjes
UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
European urology 2007;51(5):1275-80; discussion 1280.
2007: Jurgen J Fütterer; Marc R Engelbrecht; Gerrit J Jager; Robert P Hartman; Bernard F King; Christina A Hulsbergen-van de Kaa; J Alfred Witjes; Jelle O Barentsz
Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging.
European radiology 2007;17(4):1055-65.
2007: Iman J Schultz; Jacques B de Kok; J Alfred Witjes; Marko Babjuk; Johannes L Willems; Kenneth Wester; Dorine W Swinkels; Harold Tjalsma
Simultaneous proteomic and genomic analysis of primary Ta urothelial cell carcinomas for the prediction of tumor recurrence.
Anticancer research 2007;27(2):1051-8.
2007: Iman J Schultz; Lambertus A L M Kiemeney; Rian W Roelofs; Yvonne Van Aarssen; Marko Babjuk; Johannes L Willems; Per-Uno Malmstrom; Dorine W Swinkels; J Alfred Witjes; Jacques B de Kok
The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinoma.
Anticancer research 2007;27(2):1025-30.
2007: Martijn P M Q van Gils; Daphne Hessels; Onno van Hooij; Sander A Jannink; W Pim Peelen; Suzanne L J Hanssen; J Alfred Witjes; Erik B Cornel; Herbert F M Karthaus; Geert A H J Smits; Gerhard A Dijkman; Peter F A Mulders; Jack A Schalken
The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(3):939-43.
2007: Jurgen J Fütterer; Tom W J Scheenen; Stijn W T P J Heijmink; Henkjan J Huisman; Christina A Hulsbergen-van de Kaa; J Alfred Witjes; Arend Heerschap; Jelle O Barentsz
Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
Investigative radiology 2007;42(2):116-22.
2007: Iman J Schultz; Kenneth Wester; huub straatman; Lambertus A L M Kiemeney; Marko Babjuk; Jaroslav Mares; Johannes L Willems; Dorine W Swinkels; J Alfred Witjes; Per-Uno Malmstrom; Jacques B de Kok
Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma.
European urology 2007;51(2):416-22; discussion 422-3.
2007: Paula M J Moonen; B van Balken-Ory; Lambertus A L M Kiemeney; Jack A Schalken; J Alfred Witjes
Prognostic value of p53 for high risk superficial bladder cancer with long-term followup.
The Journal of urology 2007;177(1):80-3.
2006: J Roan Spermon; J Alfred Witjes
[Treatment of testicular cancer clinical stage I: watchful waiting, radiotherapy, chemotherapy or surgical intervention].
Nederlands tijdschrift voor geneeskunde 2006;150(48):2637-42.
2006: Lambertus A L M Kiemeney; Kjeld P van Houwelingen; Manon Bogaerts; J Alfred Witjes; Dorine W Swinkels; Martin den Heijer; Barbara Franke; Jack A Schalken; Gerald W Verhaegh
Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.
European journal of cancer (Oxford, England : 1990) 2006;42(18):3219-27.
2006: Kees Hendricksen; Paula M J Moonen; A G der Heijden; J Alfred Witjes
False-positive lesions detected by fluorescence cystoscopy: any association with p53 and p16 expression?
World journal of urology 2006;24(5):597-601.
2006: Jurgen J Fütterer; Stijn W T P J Heijmink; Tom W J Scheenen; Jeroen Veltman; Henkjan J Huisman; Pieter Vos; Christina A Hulsbergen-van de Kaa; J Alfred Witjes; Paul Krabbe; Arend Heerschap; Jelle O Barentsz
Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
Radiology 2006;241(2):449-58.
2006: Iman J Schultz; Kenneth Wester; huub straatman; Lambertus A L M Kiemeney; Marko Babjuk; Jaroslav Mares; Johannes L Willems; Dorine W Swinkels; J Alfred Witjes; Jacques B de Kok; Per-Uno Malmstrom
Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation study.
International journal of cancer. Journal international du cancer 2006;119(8):1915-9.
2006: Antoine G van der Heijden; Paula M J Moonen; Erik B Cornel; Henk Vergunst; Theo M de Reijke; Erika van Boven; Evert J Barten; Rajiv Puri; Coenraad K van Kalken; J Alfred Witjes
Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response.
The Journal of urology 2006;176(4 Pt 1):1349-53; discussion 1353.
2006: H T B van Moerkerk; Stijn W T P J Heijmink; Christina A Hulsbergen-V D Kaa; Jelle O Barentsz; J Alfred Witjes
Computerized three-dimensional localization of prostate cancer using contrast-enhanced power Doppler and clustering analysis.
European urology 2006;50(4):762-8; discussion 768-9.
2006: Kees Hendricksen; J Alfred Witjes
Intravesical gemcitabine: an update of clinical results.
Current opinion in urology 2006;16(5):361-6.
2006: Iman J Schultz; Lambertus A L M Kiemeney; Johannes L Willems; Dorine W Swinkels; J Alfred Witjes; Jacques B de Kok
Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence.
Clinical chemistry 2006;52(7):1440-2.
2006: J Roan Spermon; Liliana Ramos; Alex M M Wetzels; C G J Sweep; D D M Braat; Lambertus A L M Kiemeney; J Alfred Witjes
Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer.
Human reproduction (Oxford, England) 2006;21(7):1781-6.
2006: Barthold Ph Schrier; J L J Vriesema; J Alfred Witjes; Lambertus A L M Kiemeney; Jack A Schalken
The predictive value of p53, p27(kip1), and alpha-catenin for progression in superficial bladder carcinoma.
European urology 2006;50(1):76-82.
2006: Paula M J Moonen; Pim Peelen; Lambertus A L M Kiemeney; Mathilde E Boon; Jack A Schalken; J Alfred Witjes
Quantitative cytology on bladder wash versus voided urine: a comparison of results.
European urology 2006;49(6):1044-9; discussion 1049-50.
2006: Iman J Schultz; J Alfred Witjes; Dorine W Swinkels; Jacques B de Kok
Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin.
Clinica chimica acta; international journal of clinical chemistry 2006;368(1-2):20-32.
2006: Emile N J Th van Lin; Jurgen J Fütterer; Stijn W T P J Heijmink; Lisette P van der Vight; Aswin L Hoffmann; Peter van Kollenburg; Henkjan J Huisman; Tom W J Scheenen; J Alfred Witjes; Jan Willem Leer; Jelle O Barentsz; Andries Visser
IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
International journal of radiation oncology, biology, physics 2006;65(1):291-303.
2006: J Alfred Witjes
Management of BCG failures in superficial bladder cancer: a review.
European urology 2006;49(5):790-7.
2006: Kees Hendricksen; Paula M J Moonen; Antoine G van der Heijden; Janneke Molkenboer-Kuenen; Christina A Hulsbergen-van de Kaa; J Alfred Witjes
Potential and toxicity of intravesical pemetrexed: a preclinical study in pigs.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2597-601.
2006: J Alfred Witjes; Paula M J Moonen; Antoine G van der Heijden
Review pathology in a diagnostic bladder cancer trial: effect of patient risk category.
Urology 2006;67(4):751-5.
2006: Barthold Ph Schrier; M Peters; Jelle O Barentsz; J Alfred Witjes
Evaluation of chemotherapy with magnetic resonance imaging in patients with regionally metastatic or unresectable bladder cancer.
European urology 2006;49(4):698-703.
2006: Stijn W T P J Heijmink; H T B van Moerkerk; Lambertus A L M Kiemeney; J Alfred Witjes; Ferdinand Frauscher; Jelle O Barentsz
A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.
European radiology 2006;16(4):927-38.
2006: Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karl-Heinz Kurth
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.
European urology 2006;49(3):466-5; discussion 475-7.
2006: J Alfred Witjes; D O T M Melissen; Lambertus A L M Kiemeney
Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey.
European urology 2006;49(3):478-84.
2006: J Alfred Witjes
[In favour of open versus laparoscopic prostatectomy].
Nederlands tijdschrift voor geneeskunde 2006;150(3):139.
2006: Lambertus A L M Kiemeney; Roland P Kuiper; Rolph Pfundt; Simon van Reijmersdal; Mark P Schoenberg; Katja K H Aben; Martinus F Niermeijer; J Alfred Witjes; Eric F P M Schoenmakers
No evidence for large-scale germline genomic aberrations in hereditary bladder cancer patients with high-resolution array-based comparative genomic hybridization.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(1):180-3.
2006: Jurgen J Fütterer; Stijn W T P J Heijmink; Tom W J Scheenen; Gerrit J Jager; Christina A Hulsbergen-van de Kaa; J Alfred Witjes; Jelle O Barentsz
Prostate cancer: local staging at 3-T endorectal MR imaging--early experience.
Radiology 2006;238(1):184-91.
2005: Richard J Sylvester; Adrian P M van der Meijden; J Alfred Witjes; Gerhard Jakse; Norio Nonomura; Chris Cheng; Aaron Torres; Roger Watson; Karl-Heinz Kurth
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder.
Urology 2005;66(6 Suppl 1):90-107.
2005: Paula M J Moonen; Lambertus A L M Kiemeney; J Alfred Witjes
Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.
European urology 2005;48(6):951-6; discussion 956.
2005: Jurgen J Fütterer; Marc R Engelbrecht; Henkjan J Huisman; Gerrit J Jager; Christina A Hulsbergen-van de Kaa; J Alfred Witjes; Jelle O Barentsz
Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers.
Radiology 2005;237(2):541-9.
2005: Inge van Oort; B M Schout; Lambertus A L M Kiemeney; CA Hulsbergen; J Alfred Witjes
Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
European urology 2005;48(4):572-6.
2005: Iman J Schultz; Lambertus A L M Kiemeney; J Alfred Witjes; Jack A Schalken; Johannes L Willems; Dorine W Swinkels; Jacques B de Kok
CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas.
International journal of cancer. Journal international du cancer 2005;116(2):282-4.
2005: J Roan Spermon; Aswin L Hoffmann; Simon Horenblas; André L M Verbeek; J Alfred Witjes; Lambertus A L M Kiemeney
The efficacy of different follow-up strategies in clinical stage I Non-seminomatous Germ Cell Cancer: a Markov simulation study.
European urology 2005;48(2):258-67; discussion 267-8.
2005: Henkjan J Huisman; Jurgen J Fütterer; Emile N J Th van Lin; Arjan Welmers; Tom W J Scheenen; Jorn A van Dalen; Andries Visser; J Alfred Witjes; Jelle O Barentsz
Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers.
Radiology 2005;236(1):311-7.
2005: Richard J Sylvester; Adrian P M van der Meijden; J Alfred Witjes; Karl-Heinz Kurth
Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials.
The Journal of urology 2005;174(1):86-91; discussion 91-2.
2005: Barthold Ph Schrier; M Pilar Laguna; Floor van der Pal; S Isorna; J Alfred Witjes
Comparison of orthotopic sigmoid and ileal neobladders: continence and urodynamic parameters.
European urology 2005;47(5):679-85.
2005: Antoine G van der Heijden; Gerald W Verhaegh; Cornelius F J Jansen; Jack A Schalken; J Alfred Witjes
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study.
The Journal of urology 2005;173(4):1375-80.
2005: J Alfred Witjes; Paula M J Moonen; Antoine G van der Heijden
Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study.
European urology 2005;47(3):319-22.
2005: Emile N J Th van Lin; Lisette P van der Vight; J Alfred Witjes; Henkjan J Huisman; Jan Willem Leer; Andries Visser
The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study.
International journal of radiation oncology, biology, physics 2005;61(1):278-88.
2004: J Alfred Witjes; Frans M J Debruyne
Intravesical chemotherapy for superficial bladder cancer.
Nature clinical practice. Urology 2004;1(2):56-7.
2004: Jurgen J Fütterer; Tom W J Scheenen; Henkjan J Huisman; Dennis W J Klomp; Ferdi A. van Dorsten; Christina A Hulsbergen-van de Kaa; J Alfred Witjes; Arend Heerschap; Jelle O Barentsz
Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate.
Investigative radiology 2004;39(11):671-80.
2004: Antoine G van der Heijden; Cornelius F J Jansen; Gerald W Verhaegh; Michael A O'donnell; Jack A Schalken; J Alfred Witjes
The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines.
European urology 2004;46(5):670-4.
2004: Willem M L L G Deserno; Mukesh G Harisinghani; Matthias Taupitz; Gerrit J Jager; J Alfred Witjes; Peter F Mulders; Christina A Hulsbergen-van de Kaa; D Kaufmann; Jelle O Barentsz
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Radiology 2004;233(2):449-56.
2004: J Roan Spermon; J Alfred Witjes; Lambertus A L M Kiemeney
Efficacy of routine follow-up after first-line treatment for testicular cancer.
World journal of urology 2004;22(4):235-43.
2004: J Roan Spermon; Wim J G Oyen; Simon P Strijk; Christina A Hulsbergen-van de Kaa; J Alfred Witjes
Solitary skull recurrence from stage I seminomatous germ cell tumor of testis.
Urology 2004;64(2):377-9.
2004: Iman J Schultz; Lambertus A L M Kiemeney; Herbert F M Karthaus; J Alfred Witjes; Johannes L Willems; Dorine W Swinkels; Jacqueline M T Klein Gunnewiek; Jacques B de Kok
Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas.
Clinical chemistry 2004;50(8):1425-8.
2004: Cathy Balk; J Alfred Witjes
Advances in the management of testicular cancer.
Expert review of anticancer therapy 2004;4(4):669-77.
2004: Daphne Hessels; Gerald W Verhaegh; Jack A Schalken; J Alfred Witjes
Applicability of biomarkers in the early diagnosis of prostate cancer.
Expert review of molecular diagnostics 2004;4(4):513-26.
2004: Antoine G van der Heijden; Lambertus A L M Kiemeney; Ofer N Gofrit; O Nativ; A Ami Sidi; Zvi Leib; Renzo Colombo; R Naspro; M Pavone; Jack Baniel; F Hasner; J Alfred Witjes
Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder.
European urology 2004;46(1):65-71; discussion 71-2.
2004: Bas A J Verhage; Katja K H Aben; J Alfred Witjes; huub straatman; Jack A Schalken; Lambertus A L M Kiemeney
Site-specific familial aggregation of prostate cancer.
International journal of cancer. Journal international du cancer 2004;109(4):611-7.
2004: Barthold Ph Schrier; Maarten P Hollander; Bas W G van Rhijn; Lambertus A L M Kiemeney; J Alfred Witjes
Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy.
European urology 2004;45(3):292-6.
2004: Ofer N Gofrit; Amos Shapiro; Dov Pode; A Ami Sidi; O Nativ; Zvi Leib; J Alfred Witjes; Antoine G van der Heijden; R Naspro; Renzo Colombo
Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Urology 2004;63(3):466-71.
2004: J Alfred Witjes; Antoine G van der Heijden; J L J Vriesema; G J Peters; A Laan; Jack A Schalken
Intravesical gemcitabine: a phase 1 and pharmacokinetic study.
European urology 2004;45(2):182-6.
2004: J Alfred Witjes
Bladder carcinoma in situ in 2003: state of the art.
European urology 2004;45(2):142-6.
2003: J Alfred Witjes; J L J Vriesema; Antoine G van der Heijden; G J Peters; Jack A Schalken
Pharmacokinetics of intravesical gemcitabine: a preclinical study in pigs.
European urology 2003;44(5):615-9.
2003: Antoine G van der Heijden; J Alfred Witjes
Future strategies in the diagnosis, staging and treatment of bladder cancer.
Current opinion in urology 2003;13(5):389-95.
2003: George van Andel; P Fernandez de Moral; C T M Caris; P Carpentier; J Wils; M J F M de Bruin; J Alfred Witjes; Frans M J Debruyne; W P J Witjes
A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life.
World journal of urology 2003;21(3):177-82.
2003: Iman J Schultz; Lambertus A L M Kiemeney; J Alfred Witjes; Jack A Schalken; Johannes L Willems; Dorine W Swinkels; Jacques B de Kok
Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence.
Anticancer research 2003;23(4):3327-31.
2003: Daphne Hessels; Jacqueline M T Klein Gunnewiek; Inge van Oort; Herbert F M Karthaus; Geert J L H van Leenders; Bianca van Balken; Lambertus A L M Kiemeney; J Alfred Witjes; Jack A Schalken
DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.
European urology 2003;44(1):8-15; discussion 15-6.
2003: J Roan Spermon; Lambertus A L M Kiemeney; E J H Meuleman; Liliana Ramos; Alex M M Wetzels; J Alfred Witjes
Fertility in men with testicular germ cell tumors.
Fertility and sterility 2003;79 Suppl 3():1543-9.
2003: J Alfred Witjes; J L J Vriesema; K Brinkman; Gerben P Bootsma; J O Barentsz
Mycotic aneurysm of the popliteal artery as a complication of intravesical BCG therapy for superficial bladder cancer. Case report and literature review.
Urologia internationalis 2003;71(4):430-2.
2002: J Roan Spermon; J Alfred Witjes; Lambertus A L M Kiemeney
Difference in stage and morphology-adjusted survival between young and elderly patients with a testicular germ cell tumor.
Urology 2002;60(5):889-93.
2002: J Roan Spermon; Frans M J Debruyne; J Alfred Witjes
Important factors in the diagnosis and primary staging of testicular tumours.
Current opinion in urology 2002;12(5):419-25.
2002: J Roan Spermon; T A Roeleveld; Henk G van der Poel; Christina A Hulsbergen-van de Kaa; W W Ten Bokkel Huinink; M van de Vijver; J Alfred Witjes; Simon Horenblas
Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors.
Urology 2002;59(6):923-9.
2002: Maurizio Brausi; Laurence Collette; Karl-Heinz Kurth; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Donald W W Newling; Christian Bouffioux; Richard J Sylvester
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies.
European urology 2002;41(5):523-31.
2002: J Roan Spermon; Lioe-Fee de Geus-Oei; Lambertus A L M Kiemeney; J Alfred Witjes; Wim J G Oyen
The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
BJU international 2002;89(6):549-56.
2002: Katja K H Aben; J Alfred Witjes; Mark P Schoenberg; Christina A Hulsbergen-van de Kaa; André L M Verbeek; Lambertus A L M Kiemeney
Familial aggregation of urothelial cell carcinoma.
International journal of cancer. Journal international du cancer 2002;98(2):274-8.
2002: J Alfred Witjes
[Guidelines for follow-up of patients with prostate carcinoma].
Nederlands tijdschrift voor geneeskunde 2002;146(8):360-2.
2002: J Roan Spermon; Peter C M de Wilde; A G J M Hanselaar; H E Schaafsma; T E G Ruijter; J Alfred Witjes; R Jeroen A Van Moorselaar
alpha-Catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer.
BJU international 2002;89(3):278-84.
2001: Boukje van Dijk; Kjeld Van Houwelingen; J Alfred Witjes; Jack A Schalken; Lambertus A L M Kiemeney
Alcohol dehydrogenase type 3 (ADH3) and the risk of bladder cancer.
European urology 2001;40(5):509-14.
2001: Wim J G Oyen; J Alfred Witjes; Frans H M Corstens
Nuclear medicine techniques for the diagnosis and therapy of prostate carcinoma.
European urology 2001;40(3):294-9.
2001: J L J Vriesema; F Atsma; Lambertus A L M Kiemeney; W Pim Peelen; J Alfred Witjes; Jack A Schalken
Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence.
Urology 2001;58(3):367-71.
2001: J Alfred Witjes; J Roan Spermon
Prognostic factors in clinical stage 1 non-seminomatous testicular tumours.
Current opinion in urology 2001;11(5):531-4.
2001: J L J Vriesema; Katja K H Aben; J Alfred Witjes; Lambertus A L M Kiemeney; Jack A Schalken
Superficial and metachronous invasive bladder carcinomas are clonally related.
International journal of cancer. Journal international du cancer 2001;93(5):699-702.
2001: J Roan Spermon; J Alfred Witjes; M Nap; Lambertus A L M Kiemeney
Cancer incidence in relatives of patients with testicular cancer in the eastern part of The Netherlands.
Urology 2001;57(4):747-52.
2001: Katja K H Aben; Merryn V E Macville; D F Smeets; Mark P Schoenberg; J Alfred Witjes; Lambertus A L M Kiemeney
Absence of karyotype abnormalities in patients with familial urothelial cell carcinoma.
Urology 2001;57(2):266-9.
2000: Katja K H Aben; J Alfred Witjes; J A A M van Dijck; Jack A Schalken; André L M Verbeek; Lambertus A L M Kiemeney
Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin.
European journal of cancer (Oxford, England : 1990) 2000;36(18):2385-9.
2000: J L J Vriesema; M H Poucki; Lambertus A L M Kiemeney; J Alfred Witjes
Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis.
Urology 2000;56(5):793-7.
2000: NA Mungan; J L J Vriesema; C M Thomas; Lambertus A L M Kiemeney; J Alfred Witjes
Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer.
Urology 2000;56(5):787-92.
2000: Katja K H Aben; Jacqueline Cloos; N P Koper; Boudewijn J M Braakhuis; J Alfred Witjes; Lambertus A L M Kiemeney
Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma.
International journal of cancer. Journal international du cancer 2000;88(3):493-6.
2000: Henk G van der Poel; J P M Sedelaar; Frans M J Debruyne; J Alfred Witjes
Recurrence of germ cell tumor after orchiectomy.
Urology 2000;56(3):467-73.
2000: J Alfred Witjes; NA Mungan; Frans M J Debruyne
Management of superficial bladder cancer with intravesical chemotherapy: an update.
Urology 2000;56(1):19-21.
2000: NA Mungan; Katja K H Aben; Mark P Schoenberg; O Visser; Dorry Boll; J Alfred Witjes; Lambertus A L M Kiemeney
Gender differences in stage-adjusted bladder cancer survival.
Urology 2000;55(6):876-80.
2000: NA Mungan; Lambertus A L M Kiemeney; J A van Dijck; Henk G van der Poel; J Alfred Witjes
Gender differences in stage distribution of bladder cancer.
Urology 2000;55(3):368-71.
2000: Bas W G van Rhijn; Henk G van der Poel; Mathilde E Boon; Frans M J Debruyne; Jack A Schalken; J Alfred Witjes
Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.
Urology 2000;55(3):363-7.
2000: NA Mungan; Katja K H Aben; E Beeks; E Kampman; Annelies Bunschoten; M J G Bussemakers; J Alfred Witjes; Lambertus A L M Kiemeney
A germline homozygote deletion of the glutathione-S-transferase Mu1 gene predisposes to bladder cancer.
Urologia internationalis 2000;64(3):134-8.
1999: MG Steffens; Otto Boerman; P H M De Mulder; Wim J G Oyen; Wilhelmina C A M Buijs; J Alfred Witjes; Wim J M van den Broek; Jeannette C Oosterwijk-Wakka; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3268s-3274s.
1999: HP Beerlage; Geert J L H van Leenders; GO Oosterhof; J Alfred Witjes; ET Ruijter; CA van de Kaa; Frans M J Debruyne; Jean J M C H de la Rosette
High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study.
The Prostate 1999;39(1):41-6.
1999: MG Steffens; Otto Boerman; Wim J G Oyen; P H Kniest; J Alfred Witjes; GO Oosterhof; Geert J L H van Leenders; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy.
Cancer research 1999;59(7):1615-9.
1999: Jelle O Barentsz; Marc R Engelbrecht; J Alfred Witjes; Jean J M C H de la Rosette; Marinette van der Graaf
MR imaging of the male pelvis.
European radiology 1999;9(9):1722-36.
1998: G Smits; E Schaafsma; Lambertus A L M Kiemeney; C T M Caris; Frans Debruyne; J Alfred Witjes
Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression.
Urology 1998;52(6):1009-13; discussion 1013-4.
1998: J Alfred Witjes; C T M Caris; NA Mungan; Frans M J Debruyne; Wim P J Witjes
Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer.
The Journal of urology 1998;160(5):1668-71; discussion 1671-2.
1998: J Alfred Witjes; A P v d Meijden; L Collette; R Sylvester; Frans M J Debruyne; A van Aubel; Wim P J Witjes
Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and mitomycin C in superficial bladder cancer. EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group.
Urology 1998;52(3):403-10.
1998: NA Mungan; J Alfred Witjes
Bacille Calmette-Guérin in superficial transitional cell carcinoma.
British journal of urology 1998;82(2):213-23.
1998: Denis H J Schamhart; Theo M de Reijke; Henk G van der Poel; J Alfred Witjes; Elizabeth C De Boer; Karl-Heinz Kurth; Jack A Schalken
The Bard BTA test: its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer.
European urology 1998;34(2):99-106.
1998: Henk G van der Poel; Daphne Hessels; Geert J L H van Leenders; M J G Bussemakers; Jack A Schalken; J Alfred Witjes; Frans M J Debruyne
Multifocal transitional cell cancer and p53 mutation analysis.
The Journal of urology 1998;160(1):124-5.
1998: Jelle O Barentsz; O Berger-Hartog; J Alfred Witjes; C Hulsbergen-van der Kaa; GO Oosterhof; J A VanderLaak; H Kondacki; SH Ruijs
Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging.
Radiology 1998;207(3):791-7.
1998: J Alfred Witjes; Henk G van der Poel; MR van Balken; Frans M J Debruyne; Jack A Schalken
Urinary NMP22 and karyometry in the diagnosis and follow-up of patients with superficial bladder cancer.
European urology 1998;33(4):387-91.
1998: Henk G van der Poel; J Alfred Witjes; J A Schalken; F M Debruyne
Automated image analysis for bladder cancer.
Urological research 1998;26(1):1-5.
1998: Henk G van der Poel; MR van Balken; Denis H J Schamhart; Pim Peelen; T de Reijke; Frans M J Debruyne; Jack A Schalken; J Alfred Witjes
Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.
Urology 1998;51(1):44-50.
1997: Henk G van der Poel; Mathilde E Boon; P van Stratum; E C Ooms; H Wiener; Frans M J Debruyne; J Alfred Witjes; Jack A Schalken; W M Murphy
Conventional bladder wash cytology performed by four experts versus quantitative image analysis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(10):976-82.
1997: J Alfred Witjes; MR van Balken; CA van de Kaa
The prognostic value of a primary inverted papilloma of the urinary tract.
The Journal of urology 1997;158(4):1500-5.
1997: MG Steffens; Otto Boerman; Jeannette C Oosterwijk-Wakka; GO Oosterhof; J Alfred Witjes; EB Koenders; Wim J G Oyen; Wilhelmina C A M Buijs; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1529-37.
1997: J Alfred Witjes; M Wullink; GO Oosterhof; P de Mulder
Toxicity and results of MVAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced urothelial carcinoma.
European urology 1997;31(4):414-9.
1997: J Alfred Witjes
Treatment of carcinoma in situ of the urinary bladder with bropirimine.
European urology 1997;31 Suppl 1():27-30.
1996: Gerrit J Jager; Jelle O Barentsz; GO Oosterhof; J Alfred Witjes; S J Ruijs
Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.
AJR. American journal of roentgenology 1996;167(6):1503-7.
1996: Lambertus A L M Kiemeney; huub straatman; J Alfred Witjes
Decreasing bladder cancer mortality in The Netherlands.
British journal of urology 1996;78(5):686-90.
1996: Jelle O Barentsz; Gerrit J Jager; P B van Vierzen; J Alfred Witjes; S P Strijk; H Peters; Nico Karssemeijer; SH Ruijs
Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging.
Radiology 1996;201(1):185-93.
1996: Henk G van der Poel; J Alfred Witjes; P van Stratum; M E Boon; F M Debruyne; Jack A Schalken
Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer.
Urology 1996;48(3):357-64.
1996: Jacqueline Vet; J Alfred Witjes; Salvatore A E Marras; Daphne Hessels; Henk G van der Poel; F M Debruyne; Jack A Schalken
Predictive value of p53 mutations analyzed in bladder washings for progression of high-risk superficial bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(6):1055-61.
1996: Wim P J Witjes; J Alfred Witjes; GO Oosterhof; M J Debruyne
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Seminars in urologic oncology 1996;14(1 Suppl 1):10-6.
1996: Jelle O Barentsz; Gerrit J Jager; J Alfred Witjes; J H J Ruijs
Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT.
European radiology 1996;6(2):129-33.
1995: Jacqueline Vet; PP Bringuier; H E Schaafsma; J Alfred Witjes; F M Debruyne; Jack A Schalken
Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects.
Laboratory investigation; a journal of technical methods and pathology 1995;73(6):837-43.
1995: J Alfred Witjes; R Umbas; F M Debruyne; Jack A Schalken
Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer.
The Journal of urology 1995;154(6):2185-9.
1995: R J van Gils-Gielen; Wim P J Witjes; C T M Caris; F M Debruyne; J Alfred Witjes; GO Oosterhof
Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Urology 1995;45(4):581-6.
1995: P D Vegt; J Alfred Witjes; Wim P J Witjes; W H Doesburg; F M Debruyne; Adrian P M van der Meijden
A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder.
The Journal of urology 1995;153(3 Pt 2):929-33.
1994: J Alfred Witjes; Lambertus A L M Kiemeney; H E Schaafsma; F M Debruyn
The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group.
British journal of urology 1994;73(2):172-6.
1994: Lambertus A L M Kiemeney; J Alfred Witjes; R P Heijbroek; NP Koper; André L M Verbeek; F M Debruyne
Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group.
British journal of urology 1994;73(2):164-71.
1994: J Alfred Witjes; P F Mulders; F M Debruyne
Intravesical therapy in superficial bladder cancer.
Urology 1994;43(2 Suppl):2-5; discussion 6.
1994: Lambertus A L M Kiemeney; J Alfred Witjes; R P Heijbroek; F M Debruyne; André L M Verbeek
Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(11):1621-5.
1993: J Alfred Witjes
Breakage of a silicone double pigtail ureteral stent as a long-term complication.
The Journal of urology 1993;150(6):1898-9.
1993: Lambertus A L M Kiemeney; J Alfred Witjes; R P Heijbroek; André L M Verbeek; F M Debruyne
Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.
The Journal of urology 1993;150(1):60-4.
1993: Lambertus A L M Kiemeney; J Alfred Witjes; André L M Verbeek; R P Heijbroek; F M Debruyne
The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group.
British journal of cancer 1993;67(4):806-12.
1993: J Alfred Witjes; A P vd Meijden; W Doesburg; F M Debruyne
Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group.
European urology 1993;23(3):366-70.
1993: F M Debruyne; A P van der Meijden; J Alfred Witjes
Intravesical instillation therapy: alternative treatments.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;126():119-25.
1993: J Alfred Witjes; A P vd Meijden; Wim P J Witjes; W Doesburg; H E Schaafsma; F M Debruyne
A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder. Dutch South-East Cooperative Urological Group.
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1672-6.
1993: J Alfred Witjes; M P Fransen; Adrian P M van der Meijden; W H Doesburg; F M Debruyne
Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study.
Urologia internationalis 1993;51(2):67-72.
1992: Lambertus A L M Kiemeney; André L M Verbeek; P J Nelemans; J Alfred Witjes; huub straatman
Bladder cancer mortality in The Netherlands, 1955-1988.
British journal of urology 1992;70(1):46-52.
1992: J Alfred Witjes; L A Kiemeney; GO Oosterhof; F M Debruyne
Prognostic factors in superficial bladder cancer. A review.
European urology 1992;21(2):89-97.
1992: Wim P J Witjes; P M van der Meijden; E P Roos; J Alfred Witjes; Peter A Steerenberg; W Doesburg; F M Debruyne
BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale, design, and interim analysis of the trial of the South-East Cooperative Urological Group, The Netherlands.
Progress in clinical and biological research 1992;378():59-67.
1991: J Alfred Witjes; J D De Vries; H E Schaafsma; M J Bogman; J O Barentsz; R L Corten
Extramedullary plasmacytoma of the urethra: a case report.
The Journal of urology 1991;145(4):826-8.
1991: G O Oosterhof; J Alfred Witjes; F M Debruyne
Organ preservation in superficial bladder cancer.
Progress in clinical and biological research 1991;370():195-202.
1991: Elizabeth C De Boer; W H De Jong; Adrian P M van der Meijden; Peter A Steerenberg; J Alfred Witjes; P D Vegt; F M Debruyne; E J Ruitenberg
Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin.
Cancer immunology, immunotherapy : CII 1991;33(6):411-6.
1991: J Alfred Witjes; F M Debruyne
Optimal management of superficial bladder cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(3):330-3.
1991: J Alfred Witjes; F M Debruyne; Adrian P M van der Meijden
Treatment of carcinoma in situ of the urethra with intraurethral instillations of bacillus Calmette-Guérin. Case report and review of literature.
European urology 1991;20(2):170-2.
1990: J Alfred Witjes; A P vd Meijden; F M Debruyne
Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview.
Urologia internationalis 1990;45(3):129-36.
1990: F M Debruyne; J Alfred Witjes; A P vd Meijden
Intravesical bacillus Calmette-Guérin (BCG) in superficial bladder tumors. An overview.
Archivos españoles de urología 1990;43 Suppl 2():133-8.
1990: J Alfred Witjes; J D de Vries; M T Lock; F M Debruyne
Use of luteinizing-hormone-releasing hormone nasal spray in the treatment of cryptorchidism: is there still an indication? A clinical study in 78 boys with 103 undescended testicles.
European urology 1990;17(3):226-8.